LOXO-292 induces durable benefit in RET-altered thyroid cancer

LOXO-292 induces durable benefit in RET-altered thyroid cancer  HealioAmerican Thyroid Association – Ret competitors move to thyroid cancer  VantageLOXO-292 shows positive effect in RET-altered thyroid cancer in Phase 1/2 study  Seeking AlphaFull coverage

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2CxH9rN